Similar articles for PMID: 29157977

Year	Number of Results
2005	1
2006	5
2007	2
2008	3
2009	6
2010	1
2011	6
2012	8
2013	7
2014	7
2015	10
2016	7
2017	8
2018	13
2019	10
2020	8
2021	6
2022	4
2024	0

1

Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.

Deshmukh M, Nakagawa S, Higashi T, Vincek A, Venkatesh A, Ruiz de Galarreta M, Koh AP, Goossens N, Hirschfield H, Bian CB, Fujiwara N, Ono A, Hoshida H, El-Abtah M, Ahmad NB, Lujambio A, Sanchez R, Fuchs BC, Poelstra K, Prakash J, Hoshida Y; Precision Liver Cancer Prevention Consortium. Deshmukh M, et al. Nanomedicine. 2018 Feb;14(2):317-325. doi: 10.1016/j.nano.2017.11.004. Epub 2017 Nov 20. Nanomedicine. 2018. PMID: 29157977 Free PMC article.

2

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, Lauwers GY, McGinn CM, DePeralta DK, Chen X, Kuroda T, Lanuti M, Schmitt AD, Gupta S, Crenshaw A, Onofrio R, Taylor B, Winckler W, Bardeesy N, Caravan P, Golub TR, Tanabe KK. Fuchs BC, et al. Hepatology. 2014 Apr;59(4):1577-90. doi: 10.1002/hep.26898. Epub 2014 Feb 28. Hepatology. 2014. PMID: 24677197 Free PMC article.

3

Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents.

Yang X, Hou Z, Wang D, Mou Y, Guo C. Yang X, et al. Bioorg Med Chem Lett. 2020 Dec 1;30(23):127557. doi: 10.1016/j.bmcl.2020.127557. Epub 2020 Sep 16. Bioorg Med Chem Lett. 2020. PMID: 32949719

4

Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.

Wang Y, Singh R, Wang L, Nilsson M, Goonatilake R, Tong P, Li L, Giri U, Villalobos P, Mino B, Rodriguez-Canales J, Wistuba I, Wang J, Heymach JV, Johnson FM. Wang Y, et al. Oncotarget. 2016 Jul 26;7(30):47998-48010. doi: 10.18632/oncotarget.10332. Oncotarget. 2016. PMID: 27384992 Free PMC article.

5

Effect of an epidermal growth factor receptor tyrosine kinase inhibitor on actin remodeling in an in vitro bladder cancer carcinogenesis model.

Jin Y, Iwata KK, Belldegrun A, Figlin R, Pantuck A, Zhang ZF, Lieberman R, Rao J. Jin Y, et al. Mol Cancer Ther. 2006 Jul;5(7):1754-63. doi: 10.1158/1535-7163.MCT-06-0043. Mol Cancer Ther. 2006. PMID: 16891461

6

Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.

Xu L, Meng X, Xu N, Fu W, Tan H, Zhang L, Zhou Q, Qian J, Tu S, Li X, Lao Y, Xu H. Xu L, et al. Cell Death Dis. 2018 Feb 15;9(3):262. doi: 10.1038/s41419-018-0314-6. Cell Death Dis. 2018. PMID: 29449529 Free PMC article.

7

The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer.

Smith DL, Acquaviva J, Sequeira M, Jimenez JP, Zhang C, Sang J, Bates RC, Proia DA. Smith DL, et al. Target Oncol. 2015 Jun;10(2):235-45. doi: 10.1007/s11523-014-0329-6. Epub 2014 Aug 1. Target Oncol. 2015. PMID: 25077897 Free PMC article.

8

YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction.

Dai CH, Shu Y, Chen P, Wu JN, Zhu LH, Yuan RX, Long WG, Zhu YM, Li J. Dai CH, et al. Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3786-3798. doi: 10.1016/j.bbadis.2018.10.015. Epub 2018 Oct 10. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 30315932 Free article.

9

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.

Chen G, Kronenberger P, Teugels E, Umelo IA, De Grève J. Chen G, et al. BMC Med. 2012 Mar 21;10:28. doi: 10.1186/1741-7015-10-28. BMC Med. 2012. PMID: 22436374 Free PMC article.

10

Inhibition of histone deacetylases sensitizes EGF receptor-TK inhibitor-resistant non-small-cell lung cancer cells to erlotinib in vitro and in vivo.

Yu W, Lu W, Chen G, Cheng F, Su H, Chen Y, Liu M, Pang X. Yu W, et al. Br J Pharmacol. 2017 Oct;174(20):3608-3622. doi: 10.1111/bph.13961. Epub 2017 Aug 24. Br J Pharmacol. 2017. PMID: 28749535 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year